In understanding what makes the patient voice so essential to successful drug development, let’s take a critical eye to what is showing to be beneficial, particularly for mid-size pharmaceutical ...

Armed with what CEO Robert Davis called the “broadest and widest pipeline we’ve had in years,” Merck is preparing for its ...

Drug developers integrate AI capabilities as a potentially transformative strategy to combat patent cliff losses.

The CEOs at Johnson & Johnson, Pfizer and Merck have big plans for future revenue even as they face difficult odds in the ...

Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...

Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today. Rines kicks off by debunking ...

Traws Pharma, Inc. (TRAW) has disclosed a new risk, in the Corporate Activity and Growth category. The integration of Onconova and Trawsfynydd poses a significant risk to Traws Pharma, Inc.’s future ...

As this complexity deepens, a simple truth emerges: classical measurement frameworks cannot keep pace with a system that is ...

India’s pharmaceutical exports to the US will remain duty-free under a new interim trade deal, providing a major boost to ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

Lumos Pharma (NASDAQ:LUMO) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick overview of ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most promising future stocks to buy now. Piper Sandler revised the ...